Pfizer Financial Statements From 2010 to 2026

Pfizer Balance Sheet		Trends
Current Value Last Year Historical Average  10 Year Trend Total Assets 257.7 B 245.4 B 178.4 B Slightly volatile Short and Long Term Debt Total 80.9 B 77 B 46 B Slightly volatile Other Current Liabilities 34.5 B 32.8 B 18.6 B Slightly volatile Total Current Liabilities 51.9 B 49.4 B 33.3 B Slightly volatile Total Stockholder Equity 106.5 B 101.4 B 74 B Slightly volatile Property Plant And Equipment Net 11.5 B 21.2 B 14 B Slightly volatile Net Debt 79.6 B 75.8 B 43.4 B Slightly volatile Retained Earnings 140.9 B 134.2 B 88.1 B Slightly volatile Cash 2 B 1.2 B 2.4 B Slightly volatile Non Current Assets Total 196.9 B 187.5 B 131.4 B Slightly volatile Non Currrent Assets Other 11.9 B 11.3 B 6.1 B Slightly volatile Cash And Short Term Investments 15.1 B 23.5 B 20.9 B Pretty Stable Net Receivables 8.5 B 17 B 11.9 B Pretty Stable Common Stock Shares Outstanding 5.7 B 6.6 B 4.9 B Pretty Stable Liabilities And Stockholders Equity 257.7 B 245.4 B 178.4 B Slightly volatile Non Current Liabilities Total 98.9 B 94.2 B 70.8 B Slightly volatile Inventory 13.1 B 12.5 B 8.1 B Slightly volatile Other Current Assets 3.9 B 4.9 B 4.6 B Very volatile Total Liabilities 150.8 B 143.6 B 104.2 B Slightly volatile Property Plant And Equipment Gross 42.1 B 40.1 B 21.6 B Slightly volatile Total Current Assets 32.8 B 57.9 B 45.4 B Pretty Stable Short Term Debt 5.8 B 8.4 B 6.9 B Pretty Stable Intangible Assets 66.9 B 63.7 B 43.2 B Slightly volatile Property Plant Equipment 25 B 23.8 B 15.2 B Slightly volatile Accounts Payable 6.8 B 6.5 B 4.6 B Slightly volatile Common Stock Total Equity 474 M 549.7 M 454.8 M Slightly volatile Short Term Investments 20.1 B 22.3 B 19.2 B Very volatile Capital Stock 476.1 M 552 M 455.2 M Slightly volatile Common Stock 476.1 M 552 M 455.2 M Slightly volatile Other Liabilities 22.1 B 26.9 B 26.1 B Pretty Stable Other Assets 19.6 B 18.6 B 7.2 B Slightly volatile Long Term Debt 68.5 B 65.2 B 38.2 B Slightly volatile Good Will 42.1 B 78.8 B 50.2 B Slightly volatile Current Deferred Revenue 1.7 B 1.7 B 3.8 B Slightly volatile Preferred Stock Total Equity 14.5 M 15.3 M 34.5 M Slightly volatile Noncontrolling Interest In Consolidated Entity 265.1 M 246.6 M 312 M Slightly volatile Retained Earnings Total Equity 87 B 136.1 B 87.3 B Slightly volatile Long Term Debt Total 41.1 B 66 B 39.2 B Slightly volatile Capital Surpluse 90.8 B 107.6 B 85.2 B Slightly volatile Deferred Long Term Liabilities 547.2 M 576 M 11.1 B Slightly volatile Long Term Investments 2.4 B 2.6 B 11.9 B Slightly volatile Non Current Liabilities Other 16.8 B 12.7 B 20.3 B Slightly volatile Short and Long Term Debt 7.8 B 8 B 6.2 B Slightly volatile Cash And Equivalents 1.3 B 938.7 M 1.9 B Slightly volatile Net Invested Capital 136.4 B 174.6 B 123.5 B Slightly volatile
Pfizer Income Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Depreciation And Amortization 8.5 B 8.1 B 6.1 B Slightly volatile Total Revenue 39.6 B 73.2 B 54.7 B Slightly volatile Gross Profit 28.5 B 48.1 B 36.7 B Slightly volatile Other Operating Expenses 28.5 B 54.2 B 39.8 B Slightly volatile Operating Income 11.1 B 19 B 14.8 B Pretty Stable EBIT 9.8 B 12.8 B 13.2 B Pretty Stable EBITDA 13.6 B 20.8 B 19 B Pretty Stable Cost Of Revenue 26.3 B 25 B 18.9 B Slightly volatile Total Operating Expenses 17.4 B 29.2 B 21.8 B Slightly volatile Income Before Tax 8.6 B 9.2 B 11.6 B Pretty Stable Net Income 7.8 B 9.2 B 11.3 B Pretty Stable Selling General Administrative 12.9 B 13.2 B 11.7 B Very volatile Research Development 8.2 B 12.3 B 8.7 B Slightly volatile Net Income Applicable To Common Shares 12.2 B 9.2 B 12.8 B Very volatile Net Income From Continuing Ops 13.1 B 9.3 B 12 B Pretty Stable Non Recurring 1.3 B 2.1 B 1.6 B Pretty Stable Selling And Marketing Expenses 2.3 B 3 B 2.8 B Pretty Stable Interest Income 891.9 M 626.8 M 1 B Slightly volatile Reconciled Depreciation 4.4 B 6.3 B 5.8 B Slightly volatile
Pfizer Cash Flow Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Free Cash Flow 10.6 B 11.3 B 13.8 B Very volatile Begin Period Cash Flow 2.1 B 3.4 B 2.6 B Pretty Stable Depreciation 4.2 B 8.1 B 5.8 B Pretty Stable Capital Expenditures 1.9 B 3.3 B 2.2 B Slightly volatile Total Cash From Operating Activities 12.5 B 14.7 B 16 B Pretty Stable Net Income 9.3 B 9.3 B 12.3 B Very volatile End Period Cash Flow 2.1 B 1.3 B 2.5 B Slightly volatile Stock Based Compensation 1.1 B 1 B 719.6 M Slightly volatile
Financial Ratios		Trends
Current Value Last Year Historical Average  10 Year Trend Price To Sales Ratio 3.22 2.13 3.4522 Very volatile Dividend Yield 0.0598 0.057 0.0408 Slightly volatile PTB Ratio 1.86 1.96 2.7117 Pretty Stable Days Sales Outstanding 64.4 76.29 80.4301 Pretty Stable Book Value Per Share 14.77 14.06 11.8994 Slightly volatile Free Cash Flow Yield 0.0449 0.0589 0.067 Slightly volatile Operating Cash Flow Per Share 1.45 2.03 2.5811 Pretty Stable Stock Based Compensation To Revenue 0.0096 0.0124 0.0123 Slightly volatile Capex To Depreciation 0.45 0.48 0.5032 Pretty Stable PB Ratio 1.86 1.96 2.7117 Pretty Stable EV To Sales 3.54 3.06 4.142 Very volatile Free Cash Flow Per Share 1.22 1.56 2.2156 Pretty Stable ROIC 0.14 0.11 0.0976 Pretty Stable Inventory Turnover 1.5 1.81 2.263 Pretty Stable Net Income Per Share 0.94 1.27 1.8595 Pretty Stable Days Of Inventory On Hand 238 209 175 Very volatile Payables Turnover 3.03 3.48 4.0616 Pretty Stable Sales General And Administrative To Revenue 0.2 0.21 0.2038 Slightly volatile Research And Ddevelopement To Revenue 0.13 0.15 0.1556 Pretty Stable Capex To Revenue 0.0608 0.0526 0.045 Slightly volatile Cash Per Share 1.7 3.25 3.2874 Very volatile POCF Ratio 20.9 13.56 13.3434 Slightly volatile Interest Coverage 5.83 6.13 12.7962 Slightly volatile Payout Ratio 0.56 1.07 0.9075 Slightly volatile Capex To Operating Cash Flow 0.31 0.26 0.1985 Very volatile PFCF Ratio 16.69 17.57 18.1253 Pretty Stable Days Payables Outstanding 122 109 94.2512 Slightly volatile Income Quality 1.18 1.42 1.5673 Pretty Stable ROE 0.0993 0.1 0.1611 Very volatile EV To Operating Cash Flow 22.87 19.51 16.1789 Slightly volatile PE Ratio 27.61 21.55 22.1244 Slightly volatile Return On Tangible Assets 0.1 0.0807 0.1385 Very volatile EV To Free Cash Flow 42.13 25.28 23.3269 Pretty Stable Earnings Yield 0.0417 0.048 0.0569 Very volatile Intangibles To Total Assets 0.55 0.52 0.4949 Slightly volatile Net Debt To EBITDA 3.44 3.27 2.3568 Slightly volatile Current Ratio 1.73 1.35 1.5996 Slightly volatile Receivables Turnover 5.17 4.95 4.6925 Pretty Stable Graham Number 10.4 20.05 20.817 Slightly volatile Shareholders Equity Per Share 14.72 14.02 11.8369 Slightly volatile Debt To Equity 0.36 0.68 0.5587 Slightly volatile Capex Per Share 0.24 0.46 0.3655 Slightly volatile Revenue Per Share 10.62 10.11 9.1675 Slightly volatile Interest Debt Per Share 11.69 11.14 7.542 Slightly volatile Debt To Assets 0.16 0.28 0.2313 Slightly volatile Enterprise Value Over EBITDA 11.08 10.74 12.6074 Slightly volatile Short Term Coverage Ratios 1.92 1.65 3.3876 Pretty Stable Price Earnings Ratio 27.61 21.55 22.1244 Slightly volatile Operating Cycle 327 307 258 Very volatile Price Book Value Ratio 1.86 1.96 2.7117 Pretty Stable Days Of Payables Outstanding 122 109 94.2512 Slightly volatile Dividend Payout Ratio 0.56 1.07 0.9075 Slightly volatile Price To Operating Cash Flows Ratio 20.9 13.56 13.3434 Slightly volatile Price To Free Cash Flows Ratio 16.69 17.57 18.1253 Pretty Stable Pretax Profit Margin 0.17 0.11 0.2045 Slightly volatile Ebt Per Ebit 0.91 0.56 0.7937 Pretty Stable Operating Profit Margin 0.21 0.23 0.2576 Slightly volatile Company Equity Multiplier 1.71 2.18 2.3223 Very volatile Long Term Debt To Capitalization 0.37 0.35 0.3154 Slightly volatile Total Debt To Capitalization 0.24 0.39 0.3484 Slightly volatile Return On Capital Employed 0.22 0.11 0.1227 Very volatile Debt Equity Ratio 0.36 0.68 0.5587 Slightly volatile Ebit Per Revenue 0.21 0.23 0.2576 Slightly volatile Quick Ratio 1.02 0.83 1.2782 Slightly volatile Dividend Paid And Capex Coverage Ratio 1.26 0.92 1.6487 Slightly volatile Net Income Per E B T 0.7 0.9 1.0137 Slightly volatile Cash Ratio 0.0265 0.0279 0.1014 Slightly volatile Cash Conversion Cycle 218 198 169 Pretty Stable Operating Cash Flow Sales Ratio 0.2 0.18 0.2777 Slightly volatile Days Of Inventory Outstanding 238 209 175 Very volatile Days Of Sales Outstanding 64.4 76.29 80.4301 Pretty Stable Free Cash Flow Operating Cash Flow Ratio 0.58 0.69 0.792 Pretty Stable Cash Flow Coverage Ratios 0.21 0.22 0.4069 Pretty Stable Price To Book Ratio 1.86 1.96 2.7117 Pretty Stable Fixed Asset Turnover 2.68 3.11 3.8271 Very volatile Capital Expenditure Coverage Ratio 4.83 3.94 7.5304 Slightly volatile Price Cash Flow Ratio 20.9 13.56 13.3434 Slightly volatile Enterprise Value Multiple 11.08 10.74 12.6074 Slightly volatile Debt Ratio 0.16 0.28 0.2313 Slightly volatile Cash Flow To Debt Ratio 0.21 0.22 0.4069 Pretty Stable Price Sales Ratio 3.22 2.13 3.4522 Very volatile Return On Assets 0.0411 0.0432 0.0704 Pretty Stable Asset Turnover 0.59 0.34 0.3717 Pretty Stable Net Profit Margin 0.14 0.11 0.1988 Very volatile Gross Profit Margin 0.81 0.76 0.6902 Pretty Stable Price Fair Value 1.86 1.96 2.7117 Pretty Stable Return On Equity 0.0993 0.1 0.1611 Very volatile
Pfizer Valuation Data		Trends
Current Value Last Year Historical Average  10 Year Trend Market Cap 126.1 B 120.1 B 124.9 B Slightly volatile Enterprise Value 86.9 B 82.8 B 86.3 B Slightly volatile

Pfizer Fundamental Market Drivers

Pfizer Upcoming Events

About Pfizer Financial Statements

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Pfizer Inc is a strong investment it is important to analyze Pfizer's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pfizer's future performance. For an informed investment choice regarding Pfizer Stock, refer to the following important reports:

How To Invest In Pfizer Details

Is Pfizer Stock a good investment? Details

What is Pfizer's Net Worth? Details

Largest Pharmaceuticals Companies View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies View

Altman Z Score Details

Piotroski F Score Details

Beneish M Score Details

Financial Analysis Details

Buy or Sell Advice Details

Earnings Projections Details